During the past decade, LMC Diabetes & Endocrinology (Markham) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "LMC Diabetes & Endocrinology (Markham)" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "LMC Diabetes & Endocrinology (Markham)" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Impaired Glucose Tolerance" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "LMC Diabetes & Endocrinology (Markham)" in a lesser frequency.

Most popular intervention types in "LMC Diabetes & Endocrinology (Markham)" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Canakinumab 150 mg" (1 trials), "Linagliptin" (1 trials) and "Placebo to Canakinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "LMC Diabetes & Endocrinology (Markham)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "LMC Diabetes & Endocrinology (Markham)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LMC Diabetes & Endocrinology (Markham), undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in LMC Diabetes & Endocrinology (Markham), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".